| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Hypertension. 2003;41:763.)
© 2003 American Heart Association, Inc.
Scientific Contributions |
From the Specialized Center of Research in Hypertension Genetics and the Department of Internal Medicine, University of Iowa, Iowa City.
Correspondence to Kamal Rahmouni, PhD, Cardiovascular Center, University of Iowa, 524 MRC, Iowa City, IA, 52242. E-mail kamal-rahmouni{at}uiowa.edu
Leptin acts in the hypothalamus to decrease appetite and increase sympathetic nerve activity. The leptin receptor is known to signal through the janus kinase/signal transducer and activator of transcription (JAK/STAT) pathway to modulate transcription of target genes. Alteration of the activity of phosphoinositol-3 kinase (PI3K) by leptin has also been reported, and inhibition of PI3K is known to block the leptin-induced suppression of feeding. We tested the hypothesis that leptin-induced renal sympathetic nerve activation is mediated by PI3K. We evaluated renal sympathetic nerve activity (RSNA) and feeding responses of C57BL/6J mice to intracerebroventricular (ICV) administration of leptin in the presence or absence of selective inhibitors of PI3K (LY294002 or wortmannin). As expected, ICV administration of leptin decreased food intake at 4 hours and 24 hours and increased RSNA. Pretreatment with the PI3K inhibitor LY294002 markedly attenuated both the decrease in food intake and the increase in RSNA induced by leptin. Wortmannin also inhibited the RSNA response to leptin. In contrast, PI3K inhibitors did not affect the RSNA response to MTII (melanocortin-3/4 receptor agonist). Our data demonstrate that PI3K appears to play an important role in the transduction of leptin-induced changes in renal sympathetic outflow.
Key Words: hypothalamus obesity sympathetic nervous system kinase
This article has been cited by other articles:
![]() |
K. W Williams, M. M Scott, and J. K Elmquist From observation to experimentation: leptin action in the mediobasal hypothalamus Am. J. Clinical Nutrition, March 1, 2009; 89(3): 985S - 990S. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Rahmouni, C. D. Sigmund, W. G. Haynes, and A. L. Mark Hypothalamic ERK Mediates the Anorectic and Thermogenic Sympathetic Effects of Leptin Diabetes, March 1, 2009; 58(3): 536 - 542. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Morgan, D. R. Thedens, R. Weiss, and K. Rahmouni Mechanisms mediating renal sympathetic activation to leptin in obesity Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2008; 295(6): R1730 - R1736. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Gao and T. L. Horvath Cross-talk between estrogen and leptin signaling in the hypothalamus Am J Physiol Endocrinol Metab, May 1, 2008; 294(5): E817 - E826. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Zheng and H.-R. Berthoud Neural Systems Controlling the Drive to Eat: Mind Versus Metabolism Physiology, April 1, 2008; 23(2): 75 - 83. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Rahmouni and D. A. Morgan Hypothalamic Arcuate Nucleus Mediates the Sympathetic and Arterial Pressure Responses to Leptin Hypertension, March 1, 2007; 49(3): 647 - 652. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. D. Morrison, G. J. Morton, K. D. Niswender, R. W. Gelling, and M. W. Schwartz Leptin inhibits hypothalamic Npy and Agrp gene expression via a mechanism that requires phosphatidylinositol 3-OH-kinase signaling Am J Physiol Endocrinol Metab, December 1, 2005; 289(6): E1051 - E1057. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Rahmouni, M. L.G. Correia, W. G. Haynes, and A. L. Mark Obesity-Associated Hypertension: New Insights Into Mechanisms Hypertension, January 1, 2005; 45(1): 9 - 14. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. H. Bates, T. A. Dundon, M. Seifert, M. Carlson, E. Maratos-Flier, and M. G. Myers Jr LRb-STAT3 Signaling Is Required for the Neuroendocrine Regulation of Energy Expenditure by Leptin Diabetes, December 1, 2004; 53(12): 3067 - 3073. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. F. DiBona The Sympathetic Nervous System and Hypertension: Recent Developments Hypertension, February 1, 2004; 43(2): 147 - 150. [Full Text] [PDF] |
||||
![]() |
K. Rahmouni and W. G. Haynes Leptin and the Cardiovascular System Recent Prog. Horm. Res., January 1, 2004; 59(1): 225 - 244. [Abstract] [Full Text] |
||||
![]() |
M. G. Myers Jr. Leptin Receptor Signaling and the Regulation of Mammalian Physiology Recent Prog. Horm. Res., January 1, 2004; 59(1): 287 - 304. [Abstract] [Full Text] |
||||
![]() |
C. Bjorbaek and B. B. Kahn Leptin Signaling in the Central Nervous System and the Periphery Recent Prog. Horm. Res., January 1, 2004; 59(1): 305 - 331. [Abstract] [Full Text] |
||||
![]() |
A. J. Marsh, M. A.P. Fontes, S. Killinger, D. B. Pawlak, J. W. Polson, and R. A.L. Dampney Cardiovascular Responses Evoked by Leptin Acting on Neurons in the Ventromedial and Dorsomedial Hypothalamus Hypertension, October 1, 2003; 42(4): 488 - 493. [Abstract] [Full Text] [PDF] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2003 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |